NSE · GRANULES.NS
Granules India Limited
₹841.15+₹3.80 (+0.45%)
Granules India Limited’s quoted price sits in the upper half of its reported 52-week range, 8.93% below the high.
Loading market information…
NSE · IOLCP.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:02 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
IOL Chemicals and Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 19.92% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
IOL Chemicals and Pharmaceuticals Limited’s forward annual dividend is ₹1.00 per share, paid annual. The forward yield is 0.56% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
IOL Chemicals and Pharmaceuticals Limited’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow IOL Chemicals and Pharmaceuticals Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2025 | Feb 12, 2025 | ₹0.70 | ₹5.23B-6.12% vs estimate |
|---|
| Q2 2025 | Nov 14, 2024 | ₹0.66 | ₹5.26B+0.82% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹841.15+₹3.80 (+0.45%)
Granules India Limited’s quoted price sits in the upper half of its reported 52-week range, 8.93% below the high.
₹1,425.60+₹28.20 (+2.02%)
Alivus Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 4.9% below the high.
₹886.30-₹41.35 (-4.46%)
Aarti Pharmalabs Limited’s quoted price sits in the upper half of its reported 52-week range, 11.58% below the high.
₹113.35-₹5.96 (-5.0%)
Morepen Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 24.78% below the high.
₹513.00+₹27.20 (+5.6%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 2.29% below the high.
₹436.80-₹12.20 (-2.72%)
Aarti Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 18.2% below the high.
₹364.70-₹45.10 (-11.01%)
Ind-Swift Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.51% below the high.
₹306.30-₹6.55 (-2.09%)
Bajaj Healthcare Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.36% below the high.
